Global Retirement Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
ACA
Global Retirement Partners's CYTK Position: Q2 2026 in Review
Global Retirement Partners opened a new position in Cytokinetics (CYTK) in Q2 2026: 306 shares worth $26.1K. The stake represents ﹤0.01% of the portfolio and ranks #2906 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CYTK as recently as Q4 2025.
Global Retirement Partners first reported a position in CYTK in Q1 2021 and has held it in 18 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- Global Retirement Partners held 306 shares of Cytokinetics worth $26.1K as of Q2 2026.
- Cytokinetics was a new Global Retirement Partners position in Q2 2026.
- Cytokinetics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2906 holding.
- Global Retirement Partners first reported a position in Cytokinetics in Q1 2021 and has held it in 18 quarters since.
- 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.